| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 12/22/2021 | Petros Pharmaceuticals, Inc. | | Purchase | Warrant | 109.3k | $3.50 | $382.7k | See Footnote | 12/22/2021 |
| 12/22/2021 | Petros Pharmaceuticals, Inc. | | Purchase | Common Stock, par value $0.0001 per share | 145.8k | $3.43 | $500k | See Footnote | 12/22/2021 |
| 11/29/2021 | Petros Pharmaceuticals, Inc. | | Purchase | Common Stock, par value $0.0001 per share | 500k | $3.00 | $1.5M | See Footnote | 11/29/2021 |
| 11/29/2021 | Petros Pharmaceuticals, Inc. | | Purchase | Warrant | 375k | $3.50 | $1.3M | See Footnote | 11/29/2021 |
| 10/18/2021 | Petros Pharmaceuticals, Inc. | | Purchase | Warrant | 1.7M | $1.72 | $2.8M | See Footnote | 10/18/2021 |
| 10/18/2021 | Petros Pharmaceuticals, Inc. | | Purchase | Common Stock, par value $0.0001 per share | 1.7M | $1.72 | $2.8M | See Footnote | 10/18/2021 |
| 04/08/2021 | Petros Pharmaceuticals, Inc. | | Grant | Stock Option (right to buy) | 50k | $3.18 | $159k | | 04/08/2021 |
| 12/01/2020 | Petros Pharmaceuticals, Inc. | | Grant | Common Stock, par value $0.0001 per share | 3.4M | $0.00 | $0 | See Footnote | 12/01/2020 |
| 12/01/2020 | Petros Pharmaceuticals, Inc. | | Grant | Common Stock, par value $0.0001 per share | 3.4M | $0.00 | $0 | See Footnote | 12/01/2020 |